Press "Enter" to skip to content

Randomized trial of ofatumumab and bendamustine vs ofatumumab, bendamustine, and bortezomib in previously untreated patients with high-risk follicular lymphoma: CALGB 50904 (Alliance) – MD Linx

admin 0

Randomized trial of ofatumumab and bendamustine vs ofatumumab, bendamustine, and bortezomib in previously untreated patients with high-risk follicular lymphoma: CALGB 50904 (Alliance)  MD Linx

Cancer — Blum KA, et al. | June 11, 2019. Advertisement. In patients with untreated, high-risk follicular lymphoma (FL), who were enrolled in this multicenter, …

“lymphoma cancer” – Google News

(Visited 3 times, 1 visits today)

Leave a Reply

Your e-mail address will not be published. Required fields are marked *